Literature DB >> 21864664

Synthesis and characterization of mannosylated pegylated polyethylenimine as a carrier for siRNA.

Najung Kim1, Dahai Jiang, Ashley M Jacobi, Kim A Lennox, Scott D Rose, Mark A Behlke, Aliasger K Salem.   

Abstract

Regulation of gene expression using small interfering RNA (siRNA) is a promising strategy for research and treatment of numerous diseases. In this study, we develop and characterize a delivery system for siRNA composed of polyethylenimine (PEI), polyethylene glycol (PEG), and mannose (Man). Cationic PEI complexes and compacts siRNA, PEG forms a hydrophilic layer outside of the polyplex for steric stabilization, and mannose serves as a cell binding ligand for macrophages. The PEI-PEG-mannose delivery system was constructed in two different ways. In the first approach, mannose and PEG chains are directly conjugated to the PEI backbone. In the second approach, mannose is conjugated to one end of the PEG chain and the other end of the PEG chain is conjugated to the PEI backbone. The PEI-PEG-mannose delivery systems were synthesized with 3.45-13.3 PEG chains and 4.7-3.0 mannose molecules per PEI. The PEI-PEG-Man-siRNA polyplexes displayed a coarse surface in Scanning Electron Microscopy (SEM) images. Polyplex sizes were found to range from 169 to 357 nm. Gel retardation assays showed that the PEI-PEG-mannose polymers are able to efficiently complex with siRNA at low N/P ratios. Confocal microscope images showed that the PEI-PEG-Man-siRNA polyplexes could enter cells and localized in the lysosomes at 2h post-incubation. Pegylation of the PEI reduced toxicity without any adverse reduction in knockdown efficiency relative to PEI alone. Mannosylation of the PEI-PEG could be carried out without any significant reduction in knockdown efficiency relative to PEI alone. Conjugating mannose to PEI via the PEG spacer generated superior toxicity and gene knockdown activity relative to conjugating mannose and PEG directly onto the PEI backbone. Copyright Â
© 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21864664      PMCID: PMC3237934          DOI: 10.1016/j.ijpharm.2011.08.014

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  64 in total

Review 1.  Suppression of gene expression by targeted disruption of messenger RNA: available options and current strategies.

Authors:  K Y Jen; A M Gewirtz
Journal:  Stem Cells       Date:  2000       Impact factor: 6.277

2.  Uptake and intracellular fate of polyethylenimine in vivo.

Authors:  M Lecocq; S Wattiaux-De Coninck; N Laurent; R Wattiaux; M Jadot
Journal:  Biochem Biophys Res Commun       Date:  2000-11-19       Impact factor: 3.575

Review 3.  Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles.

Authors:  Donald E Owens; Nicholas A Peppas
Journal:  Int J Pharm       Date:  2005-11-21       Impact factor: 5.875

4.  Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans.

Authors:  A Fire; S Xu; M K Montgomery; S A Kostas; S E Driver; C C Mello
Journal:  Nature       Date:  1998-02-19       Impact factor: 49.962

Review 5.  Poly(ethylenimine) and its role in gene delivery.

Authors:  W T Godbey; K K Wu; A G Mikos
Journal:  J Control Release       Date:  1999-08-05       Impact factor: 9.776

6.  Silicalite nanoparticles that promote transgene expression.

Authors:  Megan E Pearce; Hoang Q Mai; Namhoon Lee; Sarah C Larsen; Aliasger K Salem
Journal:  Nanotechnology       Date:  2008-03-25       Impact factor: 3.874

7.  Photochemical enhancement of DNA delivery by EGF receptor targeted polyplexes.

Authors:  Anette Bonsted; Ernst Wagner; Lina Prasmickaite; Anders Høgset; Kristian Berg
Journal:  Methods Mol Biol       Date:  2008

8.  Mannosylated chitosan-graft-polyethylenimine as a gene carrier for Raw 264.7 cell targeting.

Authors:  Hu-Lin Jiang; You-Kyoung Kim; Rohidas Arote; Dhananjay Jere; Ji-Shan Quan; Jia-Hui Yu; Yun-Jaie Choi; Jae-Woon Nah; Myung-Haing Cho; Chong-Su Cho
Journal:  Int J Pharm       Date:  2009-04-05       Impact factor: 5.875

9.  In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis.

Authors:  Dagmar Fischer; Youxin Li; Barbara Ahlemeyer; Josef Krieglstein; Thomas Kissel
Journal:  Biomaterials       Date:  2003-03       Impact factor: 12.479

10.  Detection of siRNA administered to cells and animals by using a fluorescence intensity distribution analysis polarization system.

Authors:  Takashi Abe; Kazuhito Goda; Kazunobu Futami; Yasuhiro Furuichi
Journal:  Nucleic Acids Res       Date:  2009-03-12       Impact factor: 16.971

View more
  21 in total

Review 1.  Designing polymers with sugar-based advantages for bioactive delivery applications.

Authors:  Yingyue Zhang; Jennifer W Chan; Alysha Moretti; Kathryn E Uhrich
Journal:  J Control Release       Date:  2015-09-28       Impact factor: 9.776

2.  Recombinant high density lipoprotein nanoparticles for target-specific delivery of siRNA.

Authors:  Mengjie Rui; Hailing Tang; Yan Li; Xiaohui Wei; Yuhong Xu
Journal:  Pharm Res       Date:  2012-12-14       Impact factor: 4.200

3.  Design and evaluation of thioalkylated mannose-modified dendrimer (G3)/α-cyclodextrin conjugates as antigen-presenting cell-selective siRNA carriers.

Authors:  Keiichi Motoyama; Ryosuke Mitsuyasu; Chiho Akao; Takahiro Tanaka; Ayumu Ohyama; Nana Sato; Taishi Higashi; Hidetoshi Arima
Journal:  AAPS J       Date:  2014-09-19       Impact factor: 4.009

4.  Tuning PEGylation of mixed micelles to overcome intracellular and systemic siRNA delivery barriers.

Authors:  Martina Miteva; Kellye C Kirkbride; Kameron V Kilchrist; Thomas A Werfel; Hongmei Li; Christopher E Nelson; Mukesh K Gupta; Todd D Giorgio; Craig L Duvall
Journal:  Biomaterials       Date:  2014-11-01       Impact factor: 12.479

5.  Combination of Nanoparticle-Delivered siRNA for Astrocyte Elevated Gene-1 (AEG-1) and All-trans Retinoic Acid (ATRA): An Effective Therapeutic Strategy for Hepatocellular Carcinoma (HCC).

Authors:  Devaraja Rajasekaran; Jyoti Srivastava; Kareem Ebeid; Rachel Gredler; Maaged Akiel; Nidhi Jariwala; Chadia L Robertson; Xue-Ning Shen; Ayesha Siddiq; Paul B Fisher; Aliasger K Salem; Devanand Sarkar
Journal:  Bioconjug Chem       Date:  2015-06-25       Impact factor: 4.774

6.  Mannosylated bioreducible nanoparticle-mediated macrophage-specific TNF-α RNA interference for IBD therapy.

Authors:  Bo Xiao; Hamed Laroui; Saravanan Ayyadurai; Emilie Viennois; Moiz A Charania; Yuchen Zhang; Didier Merlin
Journal:  Biomaterials       Date:  2013-06-29       Impact factor: 12.479

7.  DNA nanoparticles with core-shell morphology.

Authors:  Preethi L Chandran; Emilios K Dimitriadis; Julianna Lisziewicz; Vlad Speransky; Ferenc Horkay
Journal:  Soft Matter       Date:  2014-08-19       Impact factor: 3.679

8.  Poly(galactaramidoamine) is an efficient cationic polymeric non-viral vector with low cytotoxicity for transfecting human embryonic kidney (HEK293) and murine macrophage (RAW264.7) cells.

Authors:  Amaraporn Wongrakpanich; Vijaya B Joshi; Aliasger K Salem
Journal:  Pharm Dev Technol       Date:  2012-01-12       Impact factor: 3.133

9.  Correlating intracellular nonviral polyplex localization with transfection efficiency using high-content screening.

Authors:  Amaraporn Wongrakpanich; Meng Wu; Aliasger K Salem
Journal:  Biotechnol Prog       Date:  2015-09-23

10.  Mannosylated biodegradable polyethyleneimine for targeted DNA delivery to dendritic cells.

Authors:  Xun Sun; Simu Chen; Jianfeng Han; Zhirong Zhang
Journal:  Int J Nanomedicine       Date:  2012-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.